CAS 116314-67-1

Entacapone

Description:

Entacapone is a chemical compound primarily used as a medication in the treatment of Parkinson's disease. It functions as a selective and reversible inhibitor of the enzyme catechol-O-methyltransferase (COMT), which plays a crucial role in the metabolism of catecholamines, including dopamine. By inhibiting this enzyme, entacapone increases the availability of levodopa, enhancing its therapeutic effects. The substance is typically administered in conjunction with levodopa and carbidopa to improve motor function in patients with Parkinson's disease. Entacapone is characterized by its molecular formula, which includes carbon, hydrogen, nitrogen, and oxygen atoms, and it has a specific molecular weight. The compound is usually presented in tablet form and is well-absorbed in the gastrointestinal tract. Common side effects may include dyskinesia, nausea, and diarrhea. As with any medication, it is essential for patients to consult healthcare professionals regarding its use, potential interactions, and contraindications.

Formula: C₁₄H₁₅N₃O₅

InChI: InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+

InChI key: InChIKey=JRURYQJSLYLRLN-BJMVGYQFSA-N

SMILES: C(=C(/C(N(CC)CC)=O)\C#N)\C1=CC(N(=O)=O)=C(O)C(O)=C1

Synonyms:

• (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
• 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (E)-
• Entacapone
• Comtan
• 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)-